![PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection | Technology Networks PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/365940/perkinelmers-oxford-immunotec-receives-us-fda-approval-for-t-cell-select-to-automate-clinically-365940-960x540.jpg?cb=11954236)
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection | Technology Networks
![Oxford Immunotec Secures FDA Approval to Expand Instrumentation of TB Detection Workflow | Clinical Lab Products Oxford Immunotec Secures FDA Approval to Expand Instrumentation of TB Detection Workflow | Clinical Lab Products](https://clpmag.com/wp-content/uploads/2022/10/tuberculosis-diagnosis-1200x900.jpg)
Oxford Immunotec Secures FDA Approval to Expand Instrumentation of TB Detection Workflow | Clinical Lab Products
![PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection - Oxford Immunotec North America PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection - Oxford Immunotec North America](https://www.oxfordimmunotec.com/assets/img/oxford_cover_photo.jpg)
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection - Oxford Immunotec North America
We're excited to announce that PerkinElmer has reached an agreement to acquire Oxford Immunotec, headquartered near Oxford, UK. This… | Instagram
Covington Represents Oxford Immunotec in its 591M Acquisition by PerkinElmer | Covington & Burling LLP
Covington Represents Oxford Immunotec in its 591M Acquisition by PerkinElmer | Covington & Burling LLP
![Oxford Immunotec Presents Data on the Use of T-SPOT.TB Test in Children over the Age of 2 toThe Korean Society of Pediatric Infectious Diseases | T-SPOT.TB: Latent TB test Oxford Immunotec Presents Data on the Use of T-SPOT.TB Test in Children over the Age of 2 toThe Korean Society of Pediatric Infectious Diseases | T-SPOT.TB: Latent TB test](https://tspot.asia/wp-content/uploads/2020/03/OI220001-scaled.jpg)